PMC:7299399 / 14808-14915 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T89","span":{"begin":24,"end":39},"obj":"Chemical"},{"id":"T90","span":{"begin":24,"end":33},"obj":"Chemical"},{"id":"T91","span":{"begin":34,"end":39},"obj":"Chemical"}],"attributes":[{"id":"A89","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A90","pred":"chebi_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A91","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"reasons, when designing antiviral drugs, clearance mechanisms have to be kept in mind. An example of this p"}